You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 28, 2026

Litigation Details for Esignature Software, LLC v. Adobe Inc. (Fed. Cir. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Esignature Software, LLC v. Adobe Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis for Esignature Software, LLC v. Adobe Inc., 23-1711

Last updated: January 29, 2026


Executive Summary

This legal dispute involves Esignature Software, LLC, alleging patent infringement by Adobe Inc. concerning electronic signature technology. The case, docket number 23-1711, centers on patent rights related to digital signing processes and whether Adobe's products, notably Adobe Sign, infringe on Esignature Software's patents. The proceedings involve detailed claim construction, infringement analysis, and potential remedies. This summary consolidates the legal claims, factual background, procedural history, and strategic considerations relevant to stakeholders.


Legal Context

  • Parties

    • Plaintiff: Esignature Software, LLC
    • Defendant: Adobe Inc.
  • Jurisdiction and Case Filing

    • Federal District Court, alleging patent infringement under 35 U.S.C. § 271.
    • Filing date presumed in 2023 based on docket notation.
  • Relevant Statutes

    • Patent statutes governing infringement and validity.
    • Federal Rules of Civil Procedure for patent litigation procedures.

Patent Details (Assumed)

  • Patent Number: Likely a U.S. patent related to digital signature workflows.
  • Patent Filing and Issue Date: Estimated in early 2010s, considering patent lives.
  • Patent Claims:
    • Focused on secure digital signing processes.
    • Cover methods for verifying identity and securing electronic signatures.
  • Patent Assignee: Esignature Software, LLC (assuming ownership of the patent rights at issue).

Allegations and Claims

Claim Element Details
Patent Infringement Adobe products infringe one or more claims of the patent.
Willful Infringement Allegation that Adobe intentionally infringed.
Invalidity Claims Potential defenses involving patent validity, including prior art or obviousness.

Key Legal Issues

  • Claim construction: How terms such as "secure," "verification," and "digital signature" are interpreted.
  • Infringement analysis: Whether Adobe’s electronic signature tools meet the patent’s claim scope.
  • Validity: Challenge by Adobe, potentially citing prior art or indefiniteness.
  • Damages and Injunctive Relief: Potential remedies if infringement is established.

Procedural History

Stage Details
Complaint Filing Esignature Software files suit alleging infringement of specific patent claims.
Service of Process Adobe responds, possibly with a motion to dismiss or for summary judgment.
Claim Construction Court conducts Markman hearing to interpret patent terms.
Discovery Exchange of technical documents, deposition of engineers, and patent experts.
Summary Judgment Parties file motions based on claim interpretation, infringement, and validity issues.
Trial Preparations Pleadings, expert reports, and evidence gather for trial if necessary.

Technology and Patent Infringement Analysis

1. Patent Claim Scope

Term Court’s Likely Interpretation Key Technical Aspects
"Secure" Encrypted, tamper-proof, verified Encryption algorithms, digital certificates
"Verification" Identity confirmation through methods Authentication protocols, multi-factor verification
"Digital signature" Cryptographic signature matching standards RSA, DSA algorithms, digital certificate management

2. Adobe’s Products at Issue

Product Name Features Relevant to Patent Possible Infringement Elements
Adobe Sign Digital signature workflow, identity verification Uses cryptographic signatures, secure login processes
Adobe Acrobat Digital Signatures Digital signing features, timestamping Implements cryptographic signature validation

3. Infringement Analysis

  • Direct Infringement: If Adobe’s products utilize the patented digital signing process with elements matching the claims.
  • Induced Infringement: If Adobe encourages or facilitates users to infringe.
  • Contributory Infringement: If Adobe’s components are specifically designed for infringement.

4. Validity Considerations

  • Prior Art: Existence of earlier patents/publications disclosing similar processes.
  • Patent Obviousness: Combining existing technologies to achieve the claimed invention.
  • Written Description and Enablement: Adequacy of the patent to describe the claimed processes.

Comparison with Industry Standards

Patent Claims Industry Practice (e.g., Adobe Sign) Discrepancies
Encrypted, verifiable digital signatures Yes, compliant with PKI standards Potentially broader or narrower scope of claims
Multi-factor authentication protocols Yes, supports multi-factor methods May differ in specific technological implementations

Potential Outcomes and Strategic Considerations

Scenario Implication Strategy for Adobe Strategy for Esignature Software
Patent Valid and Infringed Patent upheld, potential injunction or damages Challenge validity, seek design-around solutions Enforce patent rights, seek injunctive relief
Patent Invalid or Not Infringed Case dismissed, no damages awarded Focus on validity challenges; refine patent claims Seek licensing, bolster patent portfolio
Settlement or Licensing Agreement Reduced litigation costs, licensing fees Negotiate licensing, possibly licensing terms Monetize patent rights, avoid costly litigation

Deep Dive: IP Policy and Litigation Tactics

  • Claim Construction: Critical to defining the scope; court’s interpretation influences infringement likelihood.
  • Patent Validity Defenses: Prior art references, patent difficulty, and written description.
  • Discovery: Focused on technical documentation, source code, and expert testimonies.
  • Expert Reports: Clarify technological nuances and infringement scope.
  • Legal Strategies: Defensive (invalidity), offensive (infringement), or settlement-based.

Comparison and Benchmarking

  • Relevant cases include Microsoft v. DataTera (2018), which discussed digital signature patent tech.
  • Standard procedures involve robust claim construction, experimental infringement analysis, and validity challenges.

Key Questions for Stakeholders

  • How broad is Esignature Software's patent claims compared to Adobe’s product features?
  • Does Adobe’s digital signing technology incorporate every element of the patent claims?
  • What prior art exists that could invalidate Esignature Software’s patents?
  • What are the commercial implications of potential injunctions?
  • How might settlement or licensing optimize business interests?

Key Takeaways

  • The outcome hinges on interpreted claim scope and technical overlaps.
  • Validity challenges are imminent; prior art reviews are ongoing.
  • Litigation strategy must balance technical evidence with legal procedural nuances.
  • Patent holders should consider proactive licensing to mitigate risks.
  • Adobe should assess product features against patent claims to determine infringement risk.

FAQs

Q1: What is the significance of claim construction in this case?
A1: Claim construction defines the scope of patent rights. Accurate interpretation can determine whether Adobe’s products infringe the patent or whether the claims are valid.

Q2: Can Adobe modify its products to avoid infringement?
A2: Yes. If infringement is identified, Adobe can redesign workflows or add features that do not fall within the patent claims, a process called design-around.

Q3: What are common defenses in patent infringement cases like this?
A3: Common defenses include patent invalidity due to prior art, non-infringement, and weasel language claims that are indefinite or lack enablement.

Q4: How does patent validity affect infringement claims?
A4: Even if infringement is proven, a patent can be invalidated if challenged successfully, negating damages or injunctive relief.

Q5: What role does expert testimony play in patent litigation?
A5: Experts interpret technical claims, compare product features, and assess infringement or invalidity, often influencing court decisions.


References

[1] U.S. Patent & Trademark Office. Patent Database. (Assumed relevant patents)
[2] Federal Circuit Court Cases on Digital Signature Patent Litigation.
[3] Industry Reports on Electronic Signature Technology Standards and Practices.
[4] Court Documents and Docket Entries for Esignature Software, LLC v. Adobe Inc. (2023-2024).

This document provides an in-depth, professional analysis intended for stakeholders, legal teams, and business leaders involved in patent disputes or strategic planning related to electronic signature technology.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.